{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-262610","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.718993+00:00","generated_at":"2026-05-17T00:49:14.006752+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Daniel B. Soland resigns from Acadia board and governance committee chair","bullets":["Resignation effective October 30, 2025.","Mr. Soland stepped down from the Board and as Chair of Nominating and Corporate Governance Committee.","Resignation not due to any dispute or disagreement with the Company or Board.","No replacement for the Board seat or committee chair has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-262610","json":"https://secwatch.observer/filing/0001193125-25-262610.json","markdown":"https://secwatch.observer/filing/0001193125-25-262610.md","text":"https://secwatch.observer/filing/0001193125-25-262610.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/0001193125-25-262610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/acad-20251028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:49:14.006752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}